-
1 Comment
Berkeley Lights, Inc is currently in a long term downtrend where the price is trading 29.8% below its 200 day moving average.
From a valuation standpoint, the stock is 98.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 23.7.
Based on the above factors, Berkeley Lights, Inc gets an overall score of 1/5.
Exchange | NASDAQ |
---|---|
CurrencyCode | USD |
ISIN | US0843101017 |
Sector | Healthcare |
Industry | Biotechnology & Medical Research |
Market Cap | 87M |
---|---|
Target Price | 7.5 |
Dividend Yield | 0.0% |
PE Ratio | None |
Beta | 1.36 |
Berkeley Lights, Inc., a cell biology company, operates in enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products in North America, the Asia Pacific, and Europe. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BLI using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025